[Federal Register Volume 77, Number 98 (Monday, May 21, 2012)]
[Notices]
[Pages 30028-30029]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-12244]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Johnson Matthey, Inc., Pharmaceuticals Materials

    By Notice dated January 6, 2012, and published in the Federal 
Register on January 17, 2012, 77 FR 2324, Johnson Matthey, Inc., 
Pharmaceuticals Materials, 900 River Road, Conshohocken, Pennsylvania 
19428, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
following basic classes of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)...........  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Codeine (9050).............................  II
Oxycodone (9143)...........................  II
Hydrocodone (9193).........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers. The Thebaine (9333) will also be 
used to manufacture other controlled substances in bulk which will also 
be for sale in bulk to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Johnson Matthey Inc., Pharmaceuticals Materials to manufacture the 
listed basic

[[Page 30029]]

classes of controlled substances is consistent with the public interest 
at this time. DEA has investigated Johnson Matthey Inc., 
Pharmaceuticals Materials to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

    Dated: May 11, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-12244 Filed 5-18-12; 8:45 am]
BILLING CODE 4410-09-P